Janux Therapeutics Inc (JANX)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
29.10 -0.68 (-2.28%) 03/28/25 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 29.10 unch (unch) 16:02 ET
for Fri, Mar 28th, 2025
Try Excel 
Watch
-
Add or delete the symbol from one or more Watchlists.
-
Create New Watchlist
This name already in use.
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -46,535 | -34,967 | -17,459 | -63,059 | -46,994 |
| Depreciation Amortization | -4,203 | -2,595 | -1,225 | -1,342 | -453 |
| Accounts receivable | N/A | N/A | -750 | N/A | -500 |
| Accounts payable and accrued liabilities | -50 | -278 | -107 | -294 | -517 |
| Other Working Capital | -5,458 | -2,377 | -700 | 4,276 | 3,440 |
| Other Operating Activity | 15,572 | 11,252 | 6,330 | 17,497 | 14,015 |
| Operating Cash Flow | $-40,674 | $-28,965 | $-13,911 | $-42,922 | $-31,009 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -50,982 | 9,999 | -8,455 | 64,711 | 64,259 |
| PPE Investments | -1,335 | -865 | -285 | -6,445 | -4,389 |
| Investing Cash Flow | $-52,317 | $9,134 | $-8,740 | $58,266 | $59,870 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 58,717 | 2,108 | 1,580 | 500 | 309 |
| Financing Cash Flow | $58,717 | $2,108 | $1,580 | $500 | $309 |
| Beginning Cash Position | 52,242 | 52,242 | 52,242 | 36,398 | 36,398 |
| End Cash Position | 17,968 | 34,519 | 31,171 | 52,242 | 65,568 |
| Net Cash Flow | $-34,274 | $-17,723 | $-21,071 | $15,844 | $29,170 |
| Free Cash Flow | |||||
| Operating Cash Flow | -40,674 | -28,965 | -13,911 | -42,922 | -31,009 |
| Capital Expenditure | -1,335 | -865 | -285 | -6,445 | -4,389 |
| Free Cash Flow | -42,009 | -29,830 | -14,196 | -49,367 | -35,398 |